Aspiriant Defensive Valuation
| RMDFX Fund | USD 11.27 0.01 0.09% |
At this time, the entity appears to be overvalued. Aspiriant Defensive shows a prevailing Real Value of $10.33 per share. The current price of the fund is $11.27. We determine the value of Aspiriant Defensive from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Overvalued
Today
Please note that Aspiriant Defensive's price fluctuation is very steady at this time. At this time, the entity appears to be overvalued. Aspiriant Defensive shows a prevailing Real Value of $10.33 per share. The current price of the fund is $11.27. We determine the value of Aspiriant Defensive from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Aspiriant Defensive is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aspiriant Mutual Fund. However, Aspiriant Defensive's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.27 | Real 10.33 | Hype 11.27 | Naive 11.26 |
The intrinsic value of Aspiriant Defensive's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aspiriant Defensive's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aspiriant Defensive Allocation helps investors to forecast how Aspiriant mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aspiriant Defensive more accurately as focusing exclusively on Aspiriant Defensive's fundamentals will not take into account other important factors: Aspiriant Defensive Total Value Analysis
Aspiriant Defensive Allocation is at this time forecasted to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Aspiriant Defensive fundamentals before making investing decisions based on enterprise value of the companyAspiriant Defensive Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Aspiriant suggests not a very effective usage of assets in July.About Aspiriant Defensive Valuation
Our relative valuation model uses a comparative analysis of Aspiriant Defensive. We calculate exposure to Aspiriant Defensive's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aspiriant Defensive's related companies.The fund is a fund-of-funds that seeks to provide an investment return that has lower volatility than traditional asset classes by combining several non-traditional or alternative asset class exposures, including investments that focus on a specialized asset class such as long-short strategies. It is non-diversified.
Other Information on Investing in Aspiriant Mutual Fund
Aspiriant Defensive financial ratios help investors to determine whether Aspiriant Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aspiriant with respect to the benefits of owning Aspiriant Defensive security.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |